Methylation of MGMT Is Associated With Poor Prognosis in Patients With Stage III Duodenal Adenocarcinoma
PLoS ONE - United States
doi 10.1371/journal.pone.0162929
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 19, 2016
Authors
Publisher
Public Library of Science (PLoS)